Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU

被引：0
|
作者：
Yuya Sato
Shunsuke Ono
机构：
[1] The University of Tokyo,Laboratory of Pharmaceutical Regulatory Science, Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2023年 / 57卷
关键词：
Cell and gene therapy; Regulatory approval; Regulatory environment; Market entry; Clinical evidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 237
页数：10
相关论文
共 50 条
  • [21] The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built
    Coradi de Freitas, Daniel Roberto
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 213 - 219
  • [22] A Comprehensive Resource on EU Regulatory Information for Investigators in Gene Therapy Clinical Research and Advanced Therapy Medicinal Products
    Cohen-Haguenauer, Odile
    HUMAN GENE THERAPY, 2013, 24 (01) : 12 - 18
  • [23] Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products
    Lucas-Samuel, Sophie
    Ferry, Nicolas
    Trouvin, Jean-Hugues
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 73 - 85
  • [24] Regulatory Approval of CAR-T Cell and BsAb Products for Lymphoid Neoplasms in the US, EU, and Japan
    Matsuda, Kensuke
    Nonami, Atsushi
    Shinohara, Kayo
    Nagai, Sumimasa
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [25] Regulatory framework of cell therapy products
    Moussaoui, S
    Lucas, S
    Zorzi, P
    Le Saulnier, C
    Trouvin, JH
    BULLETIN DU CANCER, 2003, 90 (8-9) : 779 - 788
  • [26] Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009-2022
    Kuribayashi, Ryosuke
    Nakano, Ayuki
    Hariu, Aya
    Kishioka, Yasuhiro
    Honda, Futaba
    BIODRUGS, 2023, 37 (04) : 443 - 451
  • [27] Regulatory landscape for cell therapy - EU view
    McBlane, James W.
    BIOLOGICALS, 2015, 43 (05) : 433 - 436
  • [28] Accelerating Cell Therapy for Stroke in Japan Regulatory Framework and Guidelines on Development of Cell-Based Products
    Houkin, Kiyohiro
    Shichinohe, Hideo
    Abe, Koji
    Arato, Teruyo
    Dezawa, Mari
    Honmou, Osamu
    Horie, Nobutaka
    Katayama, Yasuo
    Kudo, Kohsuke
    Kuroda, Satoshi
    Matsuyama, Tomohiro
    Miyai, Ichiro
    Nagata, Izumi
    Niizuma, Kuniyasu
    Sakushima, Ken
    Sasaki, Masanori
    Sato, Norihiro
    Sawanobori, Kenji
    Suda, Satoshi
    Taguchi, Akihiko
    Tominaga, Teiji
    Yamamoto, Haruko
    Yamashita, Toru
    Yoshimine, Toshiki
    STROKE, 2018, 49 (04) : E145 - +
  • [29] Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
    Lee, SungKyung
    Lee, Jong Hyuk
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [30] Regulatory Frameworks for Gene and Cell Therapies in Japan
    Maeda, Daisuke
    Yamaguchi, Teruhide
    Ishizuka, Takami
    Hirata, Masakazu
    Takekita, Kazuhiro
    Sato, Daisaku
    REGULATORY ASPECTS OF GENE THERAPY AND CELL THERAPY PRODUCTS: A GLOBAL PERSPECTIVE, 2015, 871 : 147 - 162
12345